We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

26 Oct 2026 - 29 Oct 2026
16 Nov 2026 - 19 Nov 2026

Doctors Lax in Monitoring Potentially Addicting Drugs

By HospiMedica International staff writers
Posted on 14 Mar 2011
A new study claims that few primary care physicians pay adequate attention to patients taking prescription opioid drugs for chronic noncancer pain (CNCP), despite the potential for abuse, addiction, and overdose.

Researchers at Yeshiva University (YU; New York, NY, USA) conducted a retrospective cohort study using electronic medical records (EMRs) of 1,612 patients on long-term opioids treated for CNCP in eight primary care practices. More...
The researchers examined three risk reduction strategies: urine drug tests; regular office visits (at least once per 6 months and within 30 days of modifying opioid treatment); and restricted early refills (one or fewer opioid refills more than a week early). Associations of risk factors with each outcome were assessed in mixed-effects models, adjusting for patient clustering within physicians, demographics, and clinical factors.

The results showed that only a small minority (8%) of patients were found to have undergone any urine drug testing. While such testing was more common in patients at higher risk for opioid misuse, the rate of testing among those high-risk patients was still low (24%). Only half of the patients were seen regularly in the office, and patients at higher risk of opioid misuse were not seen more frequently than patients at lower risk were. Although only 23% of all patients received two or more early opioid refills, patients at greater risk for opioid misuse were more likely to receive multiple early refills. An increasing number of risk factors was positively associated with urine drug testing, but negatively associated with restricted early refills. The study was published in the March 2, 2011, online edition of the Journal of General Internal Medicine.

"We were disturbed to find that patients with a drug use disorder were seen less frequently in the office and were prescribed more early refills than patients without these disorders,” said lead author Joanna Starrels, MD, MS, an assistant professor of medicine at the YU Albert Einstein College of Medicine. "The finding that physicians did not increase precautions for patients at highest risk for opioid misuse should be a call for a standardized approach to monitoring.”

Prescription drug misuse is a major public health problem. An estimated 48 million people over the age of 12 in the United States have taken prescription drugs for nonmedical uses in their lifetime, which represents approximately 20% of the US population. Opioids, central nervous system depressants, and stimulants were the drugs most commonly abused.

Related Links:

Yeshiva University




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Surgical Dressing
ALLEVYN Ag+ SURGICAL
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image:The NCIBT team with the cath lab members celebrating the completion of the study. (Image Credit: UC Davis)

Dual-Imaging Catheter Completes Initial Human Evaluation of Coronary Plaque

Atherosclerosis involves plaque buildup in arterial walls that can narrow blood vessels and increase the risk of heart attack, stroke, and other serious cardiovascular conditions. In coronary arteries,... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.